There are currently multiple approaches that are effective in patients initiating antiretroviral therapy Recommended treatment choices are based on a dual combination 'backbone' consisting of two nucleoside reverse transcriptase inhibitors plus a protease inhibitor or non-nucleoside reverse transcriptase inhibitor. A novel approach being studied is a regimen that consists of three nuclesides only. Therapeutic decisions need to encompass a long-term strategy that is individualized and likely to provide optimal viral suppression that is tolerable as well as effective.
|Original language||English (US)|
|Number of pages||5|
|Journal||International Antiviral News|
|State||Published - Dec 1 1999|
ASJC Scopus subject areas